BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22665054)

  • 1. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
    Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer.
    Li J; Kong F; Wu K; Song K; He J; Sun W
    Mol Med Rep; 2014 Nov; 10(5):2613-20. PubMed ID: 25215905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS; Kolb EA; Mills CC; Sampson VB
    Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer.
    Li XF; Yan PJ; Shao ZM
    Oncogene; 2009 Nov; 28(44):3937-48. PubMed ID: 19701247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-193b Regulates Mcl-1 in Melanoma.
    Chen J; Zhang X; Lentz C; Abi-Daoud M; Paré GC; Yang X; Feilotter HE; Tron VA
    Am J Pathol; 2011 Nov; 179(5):2162-8. PubMed ID: 21893020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.
    Wong QW; Lung RW; Law PT; Lai PB; Chan KY; To KF; Wong N
    Gastroenterology; 2008 Jul; 135(1):257-69. PubMed ID: 18555017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-423-5p Inhibits Osteosarcoma Proliferation and Invasion Through Directly Targeting STMN1.
    Wang X; Peng L; Gong X; Zhang X; Sun R; Du J
    Cell Physiol Biochem; 2018; 50(6):2249-2259. PubMed ID: 30423576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-101 inhibits cell proliferation and invasion of pancreatic cancer through targeting STMN1.
    Zhu L; Chen Y; Nie K; Xiao Y; Yu H
    Cancer Biomark; 2018; 23(2):301-309. PubMed ID: 30198871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1.
    Li J; Hu GH; Kong FJ; Wu KM; He B; Song K; Sun WJ
    Neoplasma; 2014; 61(2):144-52. PubMed ID: 24299310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-193b directly targets STMN1 and inhibits the malignant phenotype in colorectal cancer.
    Guo F; Luo Y; Mu YF; Qin SL; Qi Y; Qiu YE; Zhong M
    Am J Cancer Res; 2016; 6(11):2463-2475. PubMed ID: 27904764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-193b represses cell proliferation and regulates cyclin D1 in melanoma.
    Chen J; Feilotter HE; Paré GC; Zhang X; Pemberton JG; Garady C; Lai D; Yang X; Tron VA
    Am J Pathol; 2010 May; 176(5):2520-9. PubMed ID: 20304954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-193b promotes cell proliferation by targeting Smad3 in human glioma.
    Zhong Q; Wang T; Lu P; Zhang R; Zou J; Yuan S
    J Neurosci Res; 2014 May; 92(5):619-26. PubMed ID: 24496888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural Mesothelioma.
    Birnie KA; Yip YY; Ng DC; Kirschner MB; Reid G; Prêle CM; Musk AW; Lee YC; Thompson PJ; Mutsaers SE; Badrian B
    Mol Cancer Res; 2015 Jul; 13(7):1106-18. PubMed ID: 25824152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a Regulates Expression of the Stathmin-1 Oncoprotein and Prostate Cancer Progression.
    Chakravarthi BVSK; Chandrashekar DS; Agarwal S; Balasubramanya SAH; Pathi SS; Goswami MT; Jing X; Wang R; Mehra R; Asangani IA; Chinnaiyan AM; Manne U; Sonpavde G; Netto GJ; Gordetsky J; Varambally S
    Mol Cancer Res; 2018 Jul; 16(7):1125-1137. PubMed ID: 29025958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
    Sarver AL; Li L; Subramanian S
    Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.
    Kappelmann M; Kuphal S; Meister G; Vardimon L; Bosserhoff AK
    Oncogene; 2013 Jun; 32(24):2984-91. PubMed ID: 22797068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.
    Kaukoniemi KM; Rauhala HE; Scaravilli M; Latonen L; Annala M; Vessella RL; Nykter M; Tammela TL; Visakorpi T
    Cancer Med; 2015 Sep; 4(9):1417-25. PubMed ID: 26129688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.